Yoshihiro Uto

Prof. Dr. Yoshihiro Uto

Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Anticancer Research
Verified
Journal Article
Open access
PDF file
JIJunya Iwasaki
Junya Iwasaki
TKToshiharu Komori
Toshiharu Komori
FNFumio Nakagawa
Fumio Nakagawa
HNHideki Nagase
Hideki Nagase
JUJunji Uchida
Junji Uchida
YUYoshihiro Uto
Yoshihiro Uto
Background/Aim: Trabectedin is a DNA-damaging agent and has been approved for the treatment of patients with advanced soft tissue sarcoma. Schlafen 11 (SLFN11) was identified as a dominant determinant of the response to DNA-damaging agents. The aim of the study was to clarify the association between SLFN11 expression and the antitumor activity of trabectedin. Materials and Methods: The antitumor activity of trabectedin was evaluated under different expression levels of SLFN11 regulated by RNA interference and CRISPR-Cas9 systems, and the combined antitumor activity of ataxia telangiectasia and Rad3-related protein kinase (ATR) inhibitor and trabectedin in sarcoma cell lines using in vitro a cell viability assay and in vivo xenograft models. Results: SLFN11-knockdown cell lines had a lower sensitivity to trabectedin, compared to parental cells. ATR inhibitor enhanced the antitumor activity of trabectedin in SLFN11-knockdown cells and in a SLFN11-knockout xenograft model. Conclusion: SLFN11 expression might be a key factor in the antitumor activity of trabectedin.

27 March 2017 in Molecules
Verified
Journal Article
Open access
PDF file
TOTomohiro Osaki
Tomohiro Osaki
KAKazuo Azuma
Kazuo Azuma
YMYusuke Murahata
Yusuke Murahata
TTTakeshi Tsuka
Takeshi Tsuka
Norihiko ItoNorihiko Ito
Norihiko Ito
YOYoshiharu Okamoto
Yoshiharu Okamoto
Sonodynamic therapy (SDT) kills tumor cells through the synergistic effects of ultrasound (US) and a sonosensitizer agent. 5-Aminolevulinic acid (5-ALA) has been used as a sonodynamic sensitizer for cancer treatment. However, studies have shown that 5-ALA-based SDT has limited efficacy against malignant tumors. In this study, we examined whether artesunate (ART) could enhance the cytotoxicity of 5-ALA-based SDT against mouse mammary tumor (EMT-6) cells in vitro. In the ART, ART + US, ART + 5-ALA, and ART + 5-ALA + US groups, the cell survival rate correlated with ART concentration, and decreased with increasing concentrations of ART. Morphologically, many apoptotic and necrotic cells were observed in the ART + 5-ALA + US group. The percentage of reactive oxygen species-positive cells in the ART + 5-ALA + US group was also significantly higher than that in the 5-ALA group (p = 0.0228), and the cell death induced by ART + 5-ALA + US could be inhibited by the antioxidant N-acetylcysteine. These results show that ART offers great potential in enhancing the efficacy of 5-ALA-based SDT for the treatment of cancer. However, these results are only based on in vitro studies, and further in vivo studies are required.

3 July 2018 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
TKTomoko Kaneko
Tomoko Kaneko
MTMasahide Tominaga
Masahide Tominaga
RKRisa Kouzaki
Risa Kouzaki
AHAyaka Hanyu
Ayaka Hanyu
KUKazuki Ueshima
Kazuki Ueshima
YUYoshihiro Uto
Yoshihiro Uto
Background/Aim: Carbon-ion beam is one of the most advanced radiations used for cancer treatment. However, there are tumors that are difficult to suppress with carbon-ion beam alone, thus necessitating development of drugs that can enhance its therapeutic effect. In this regard, the radiosensitizing effect of 5-aminolevulinic acid (ALA) and protoporphyrin IX (PpIX), that is a metabolic intermediate of ALA, on carbon-ion beam was investigated. Materials and Methods: Radiosensitizing activity, mitochondrial ROS and DNA double-strand break production of ALA and PpIX were evaluated by irradiation with 1.0 or 1.5-Gy carbon-ion beam to mouse mammary EMT6 tumor cells. Results: Combination of carbon-ion beam and ALA or PpIX showed a significant enhancement of its cytotoxic activity through a significant increase in ROS production in mitochondria. Furthermore, the combined activity of carbon-ion beam and ALA resulted in a significant increase in DNA double-strand breakage. Conclusion: ALA selectively accumulates in the mitochondria and PpIX synthesized from ALA reacts with carbon-ion beam to produce ROS that exert antitumor activity.

1 July 2016
Verified
Journal Article
Closed access
YSYoshiki Shimamura
Yoshiki Shimamura
DTDai Tamatani
Dai Tamatani
SKSyota Kuniyasu
Syota Kuniyasu
YMYusuke Mizuki
Yusuke Mizuki
TSTakuma Suzuki
Takuma Suzuki
YUYoshihiro Uto
Yoshihiro Uto

1 August 2021 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
KSKoichiro Shinji
Koichiro Shinji
TCTaiichiro Chikama
Taiichiro Chikama
SOShigetoshi Okazaki
Shigetoshi Okazaki
YUYoshihiro Uto
Yoshihiro Uto
KSKentaro Sueoka
Kentaro Sueoka
TSTakemasa Sakaguchi
Takemasa Sakaguchi

3 July 2018 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
TTToru Tasaka
Toru Tasaka
EKEmi Kuwada
Emi Kuwada
YIYuka Izuchi
Yuka Izuchi
RNRyohei Nishigawa
Ryohei Nishigawa
HYHisatsugu Yamada
Hisatsugu Yamada
YUYoshihiro Uto
Yoshihiro Uto
Background/Aim: Whey protein is a mixture of globulins isolated from whey and mainly composed of β-lactoglobulin, α-lactoalbumin, and lactoferrin. In this study, whey protein was hydrolyzed using various proteases, and the macrophage activation was evaluated. Materials and Methods: Hydrolyzed whey protein was prepared using various proteases to evaluate phagocytic activity and cytokine productivity. Results: The results of SDS-PAGE and gel permeation chromatography (GPC) analysis indicated that the molecular weight of whey protein was reduced using various proteases. The hydrolyzed whey protein showed a concentration-dependent induction of macrophage phagocytic activity. In addition, the hydrolyzed whey protein significantly enhanced the production of the inflammatory cytokine, TNF-α. Production of the anti-inflammatory cytokine, IL-10, was not observed at concentrations up to 1 μg, but significant production was confirmed at 100 μg. Conclusion: Hydrolyzed whey protein can induce the phagocytic activity of macrophages and activation of the inflammatory/anti-inflammatory functions of the macrophages depends on the concentration of the hydrolyzed whey protein.